Blood and tumor genetic study for BRCA and related risks
Part of Cancer, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.
This study collects blood (and possibly tumor tissue) to learn how certain inherited gene changes relate to breast and ovarian cancer risk. It may help researchers understand which people are most likely to develop these cancers and how tumors differ in high-risk patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with a high risk for breast or ovarian cancer
- You either have a known inherited (germline) gene change in BRCA1 or BRCA2 (or other listed genes), or you have a strong family history
- You do not already have a known inherited cancer-risk gene mutation (for the family-history route)
- You are getting ready for surgery to remove a pelvic mass (a growth in the pelvis)
- The pelvic mass is considered suspicious based on imaging (scan) or a clinician’s exam
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study looks at blood and tissue samples from people newly diagnosed with breast cancer to better understand the disease and possibly find better ways to treat it. It is for people who have not yet started treatment, so it may be an opportunity to contribute to research early in your journey.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study follows women who carry BRCA1 or BRCA2 gene variants (or a gene variant of unclear meaning) to learn about their risks over time. It may help improve how genetic information is used to guide future care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.